Joseph Waling
Interventional Pain Medicine · Newburgh, INNPI 1114902160
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 176 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 29.3% of the total. Reporting peaked in 2019 at $1,144 and has fallen 58.8% since, to $472 in 2023. That places this record below the midpoint for interventional pain medicine clinicians in IN, where the typical reported total is $4,157.
Across 176 payments — averaging $19.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Medtronic$666
- Nevro Corp.$570
- Amgen$183
- Novartis$122
- Boston Scientific$111
- plus $790 from 21 others
What the payments were for
- Food & beverage$3,452100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 70 | $1,010 |
| Medtronic(2 entities) | 26 | $666 |
| Nevro Corp. | 16 | $570 |
| Amgen(2 entities) | 10 | $183 |
| Novartis | 7 | $122 |
| Boston Scientific | 2 | $111 |
| Stimwave Technologies Incorporated | 1 | $109 |
| Abbott | 6 | $91 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $69 |
| Sanofi-aventis U.S. LLC | 4 | $63 |
| Radius Health, Inc. | 3 | $58 |
| Tersera Therapeutics LLC | 3 | $43 |
| Avanir Pharmaceuticals, Inc. | 2 | $39 |
| Daiichi Sankyo Inc. | 2 | $37 |
| Pfizer | 3 | $36 |
| Vertos Medical, Inc. | 1 | $35 |
| Biodelivery Sciences International, Inc. | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 2 | $24 |
| AstraZeneca | 2 | $24 |
| Lilly USA, LLC | 2 | $23 |
| Averitas Pharma Inc. | 1 | $19 |
| Saol Therapeutics Inc. | 1 | $18 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $17 |
| Painteq LLC | 1 | $16 |
| Shionogi Inc | 1 | $15 |
| Si-bone, Inc. | 1 | $12 |
| Pernix Therapeutics Holdings, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,452 in reported general payments places this provider in the 45th percentile of 68 interventional pain medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $584 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $551 |
| Gabapentin | 15 | $154 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Newburgh
- Marjorie OropillaNewburgh$4K
- Joshua WellingtonCarmel$315K
- Joseph RutledgeLafayette$96K
- Orlando LandrumElkhart$34K
- Mahendra SanapatiEvansville$31K
- Nikhil ShettyMunster$29K
- David GordonIndianapolis$28K
- Vinayak BelamkarIndianapolis$28K
- Jocelyn BushIndianapolis$20K
- Scott KimGreenwood$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.